UCL SCHOOL OF PHARMACY
Academic Regulations for the MPharm Degree
These Academic Regulations apply to MPharm students who began the programme in or
before 2012/13. Students who started the MPharm in 2013/14 should refer to the UCL Academic
Regulations and the Exceptions listed on the School web page.
1.
INTRODUCTION AND TERMINOLOGY ................................................................... 3
2.
REGISTRATION PERIOD AND CHANGES TO PATTERN OF STUDY.................... 3
3.
BOARD OF EXAMINERS.......................................................................................... 4
4.
DATES OF EXAMINATIONS .................................................................................... 4
5.
ENTRY TO ASSESSMENTS ..................................................................................... 4
6.
REQUIREMENTS TO PASS A MODULE.................................................................. 5
7.
ACADEMIC PROGRESSION .................................................................................... 6
8.
RESIT PROVISIONS ................................................................................................. 6
9.
COURSEWORK PROVISIONS ................................................................................. 7
10.
EXAMINATION PROCEDURES ................................................................................ 8
11.
EXTENUATING CIRCUMSTANCES ......................................................................... 8
12.
SPECIAL EXAMINATION ARRANGEMENTS .......................................................... 9
13.
ACADEMIC MISCONDUCT AND PLAGIARISM ....................................................... 9
14.
HONOURS CLASSIFICATION ................................................................................ 10
15.
EXIT QUALIFICATION ............................................................................................ 10
16.
DATE OF DEGREE AWARD .................................................................................. 10
17.
PROVISION OF DEGREE CERTIFICATE ............................................................... 10
18.
AEGROTAT DEGREE ............................................................................................. 11
1
19.
AWARD OF DEGREES, DIPLOMAS AND CERTIFICATES ................................... 11
20.
APPEALS................................................................................................................ 11
21.
REVOCATION OF AWARDS .................................................................................. 11
22.
SCHEME OF AWARD ............................................................................................. 11
Annex A: Students who commenced the MPharm in 2009/10................................. 12
Annex B: Students who commenced the MPharm in 2010/11................................. 16
Annex C: Students who commenced the MPharm in 2011/12................................. 20
Annex D: Students who commenced the MPharm in 2012/13................................. 23
2
1.
INTRODUCTION AND TERMINOLOGY
1.1
This document sets out the Academic Regulations which govern the MPharm programme
at the UCL School of Pharmacy for the academic year 2015/16. MPharm students will be
governed by these Academic Regulations as well as UCL’s academic policies and
procedures where specified.
1.2
Students will be subject to the Academic and Degree Regulations in place at the start of
their programme of study. There may be amendments to these regulations during a
student’s registration on their programme of study and they will be notified of any changes
in advance. Schemes of Award for students entering the programme from 2009/10 onwards
are available in the Annexes at the end of these Regulations.
1.3
The following terminology will be used throughout these regulations:





Programme of Study: This is the MPharm degree. Students who wish to exit the
degree at the end of Year 3 may be eligible for the BSc Pharmaceutical Studies.
Modules: The MPharm will comprise a number of modules. These will be outlined in
the MPharm Programme Handbook and in the Scheme of Award outlined in the
Annexes at the end of these Regulations.
Part: The MPharm programme is divided into four Parts (years). Each Part is a
progression point on the MPharm degree. Students cannot progress to the next Part
of the MPharm until the previous part has been completed and passed.
Programme Director: Academic member of staff who is responsible for the overall
management and academic leadership of the MPharm Degree.
Module Organiser: Academic member of staff who is responsible for the overall
management and academic leadership of an individual Module.
2.
REGISTRATION PERIOD AND CHANGES TO PATTERN OF STUDY
2.1
Period of Registration
2.1.1
The normal period of registration for the MPharm is:
Programme of study
MPharm
2.1.2
2.2
Minimum
4 years
The General Pharmaceutical Council (GPhC) has introduced a registration
requirement of 8 years. This includes the completion of the MPharm and the preregistration training as well as making an application to register as a pharmacist.
Students who interrupt their studies or are required to take a year out to complete
outstanding assessments must complete the MPharm within the maximum period
of registration outlined above, or seek advice from the GPhC if they intend to
register as a pharmacist in Great Britain.
Changes to Pattern of Study
2.2.1
Interruption of Study: Refer to the UCL procedure available here.
3
2.2.2
Withdrawal of Study: Refer to the UCL procedure available here.
3.
BOARD OF EXAMINERS
3.1
The MPharm Board of Examiners is governed by the UCL Regulations for the Board of
Examiners for Taught Programmes.
3.2
There are three types of Board of Examiners for the MPharm:



Interim/Module Board: This Board approves provisional module marks but cannot
make progression or award recommendations.
Main Board: This Board approves modules results and any results approved by an
Interim/Module Board. It also makes progression and award recommendations to
the Faculty Board of Examiners.
Resit/Deferral Board: This Board approves resit and first sit module results and any
results approved by an Interim/Module Board. It also makes progression and award
recommendations to the Faculty Board of Examiners.
4.
DATES OF EXAMINATIONS
4.1
The School has three main examination periods as follows:



January/February for modules taught in Term 1 only
April/May/June for modules taught in Term 2 only and year-long modules
Resit/Deferrals (September) for all modules
4.2
Some examinations may be held outside of the three main periods listed in 4.1 and this will
be detailed in the Module Handbook at the start of the module.
4.4
A timetable of examinations showing the date, time and location of the examinations will be
published by the School of Pharmacy Student and Academic Support Office (SASO) or the
UCL Examinations Section at least one month in advance of the examination period.
5.
ENTRY TO ASSESSMENTS
5.1
A student will be entered for all assessments for a Module as long as they have attended
the programme of study and pursued the module to the satisfaction of their tutors. The
minimum requirement for ‘satisfactory performance’ is attendance of 70% of the module in
terms of lectures, seminars, laboratory sessions and other forms of teaching and learning
as specified by the School. If this is not the case then the tutor will inform the Student and
Academic Support Office (SASO) at least two weeks’ prior to the date of the first
assessment for which entry has been refused. The Student and Academic Support Office
(SASO) will in turn, notify the student.
4
5.2
A student is required to enter the diet of assessments for each Module at the first available
opportunity. In the case of approved extenuating circumstances, a student may be
permitted to defer assessments to the next available opportunity.
5.3
All assessed work, whether written papers or oral examination, shall be assessed in the
English Language.
6.
REQUIREMENTS TO PASS A MODULE
6.1
A Module may include one or more separate assessment components such as
examinations, essays, practical work, presentations etc. The methods of assessment for
each component will be set out in the Module Handbook for each Module. Further
information about of assessment can be found in the UCL Assessment Strategy.
6.2
Students must complete a number of formative and summative assessments as detailed in
the Module Handbook. Formative assignments give feedback to students on their
performance but do not count towards the final mark. The marks for summative
assignments count towards the final mark for the Module. The weighting of each
assessment component for the final Module mark will be detailed in the Module Handbook
and in the Schemes of Award in the Annexes to these Regulations.
6.3
Students are required to participate in all assessment components at the first available
opportunity. Students are only permitted to defer their assessment due to accepted
Extenuating Circumstances.
6.4
The minimum pass mark for Modules are:
 40% for Undergraduate Modules (PHAY1000, PHAY2000, PHAY3000)
 50% for Postgraduate Modules (PHAYMX99, PHAYM001, Options)
6.5
Some Modules have individual pass marks for each separate assessment component
within the Module which are known as qualifying pass marks. It is possible for students to
achieve the minimum pass mark for the Module but fail due to not achieving the qualifying
pass mark for the individual assessment components. It is also possible for some
assessment components to have higher qualifying pass marks than the minimum Module
pass marks outlined in 6.4. This will be detailed in the Module Handbook and in the
Scheme of Award in the annexes to these regulations.
6.6
A student who is absent from assessments without good cause will incur a penalty. For
written examinations this will be a mark of zero and for coursework this will either be a mark
of zero or a late penalty mark deduction depending on the lateness of the submission. The
coursework penalties are outlined in UCL Academic Regulations for Undergraduate
Students Section 3, point 3.1.6.
6.7
Where students have extenuating circumstances which render them not fit to sit an
assessment, they must report these to the Extenuating Circumstances Panel (ECP), via the
Student and Academic Support Office (SASO), as soon as practically possible and within
the deadlines set out on the http://www.ucl.ac.uk/pharmacy/current-students/studentinformation/regulations. If the EC’s are accepted by the ECP then no penalty will be
incurred.
5
7.
ACADEMIC PROGRESSION
7.1
In order to progress, students must have completed and passed all assessments
associated with each part of the MPharm.
7.2
Where a student has failed assessments within a part then the resit provisions will apply as
set out in Section 8 below.
7.3
Students cannot progress to the next part of a programme until they have completed and
passed the previous part.
7.4
It is not possible to trail failed or incomplete Modules into the next part of the MPharm.
8.
RESIT PROVISIONS
8.1
If a student has passed a Module or been awarded the MPharm or BSc Pharmaceutical
Studies then they cannot resit an assessment.
8.2
A candidate who has failed an assessment at the first attempt may be permitted an
opportunity to re-enter for the assessment at a later date specified by the Board of
Examiners.
8.3
The right to resit an assessment is not automatic and is at the discretion of the Board of
Examiners. Students whose performance is exceptionally poor may be required to repeat
the failed assessments with attendance or they may be required to withdraw from the
programme.
8.4
Resit assessments will be in the same format as the assessments taken at the first
opportunity. Where an identical assessment cannot be offered an alternative form of
assessment may be set which allows the candidate to demonstrate achievement of the
learning outcomes for that assessment. However, if the original assessment has to be
passed, the student may be required to sit out the academic year and repeat the
assessment at the next available opportunity. They will not be permitted to progress to the
next Part until the assessment has been passed.
8.5
A maximum of two attempts at each assessment is permitted at the discretion of the Board
of Examiners. Where a student has failed 50% or more of a part, the Board of Examiners
may ask the student to withdraw from the programme without the opportunity for resits. A
third attempt may be granted by the Board of Examiners in exceptional circumstances such
as a marginal fail in a Module or accepted extenuating circumstances.
8.6
The maximum mark that can be achieved at a resit assessment will be the minimum pass
mark for that assessment component. The minimum pass marks obtained at resit will be
used for calculating the overall pass mark for the Module and the final degree award.
6
8.7
Marks achieved at the resit opportunity will be capped and will override any marks achieved
at previous attempts. This will be the case even where the marks achieved at the resit
opportunity are lower than those achieved previously.
8.8
Students who are required to take an assessment component as a deferred first attempt
due to accepted extenuating circumstances will not be capped at the minimum pass mark
for that assessment component. The student will be credited with the actual mark received
for that assessment component.
8.9
Students who fail some assessment components for a Module but pass others will be
credited with the marks for the assessments they have passed and will not be required to
repeat them. However, where a student has been granted an exceptional third attempt at
an assessment by the Board of Examiners, they may be required to forfeit marks already
gained in the Module and repeat all assessments with or without attendance.
8.10
A candidate who fails an assessment must satisfy the examiners at the next available
opportunity and within 13 months from the date of the first entry to the examination. A
candidate who fails to satisfy the examiners within this period will not be permitted to
progress and may be required to re-attend the Module before being entered for any further
assessment opportunity.
9.
COURSEWORK PROVISIONS
9.1
Students must submit coursework in accordance with the procedures set out in the Student
Handbook. They must also follow any specific requirements set out in the MPharm
Programme Handbook and in individual Module Handbooks.
9.2
All coursework submitted in hard copy must have a completed Coursework Coversheet
attached. An electronic version of the Coursework Coversheets is available on Moodle.
9.3
Coursework which is submitted late and without valid Extenuating Circumstances will be
subject to the penalties outlined in the UCL Academic Regulations for Undergraduate
Students Section 3, point 3.1.6.
9.4
Extension to submission dates for coursework/projects can only be approved via the
Extenuating Circumstances procedure. Academic staff cannot approve extensions to
deadlines.
9.5
Penalties will be imposed for over length coursework, including research projects,
dissertations and final reports as outlined in the UCL Academic Regulations for
Undergraduate Students, Section 3, point 3.1.7.
10.
EXAMINATION PROCEDURES
10.1
UCL has established procedures for the conduct of examinations which are printed
annually. These can be found on the School web site under examinations.
7
10.2
Information about the Examination Procedures will be sent to students prior to each
examination session by email and individual timetables can be found within your portal in
Portico. If students do not receive this information it is their responsibility to inform the
Student and Academic Support Office (SASO). Students must familiarise themselves with
the Examination procedures available on the School website prior to each examination
period.
10.3
Any breach of the Examination procedures will be dealt with under the UCL Examination
Irregularities Procedure and/or Fitness to Practise procedures.
11.
EXTENUATING CIRCUMSTANCES
11.1
The School operates a “fit to sit” Extenuating Circumstances Policy. If a student believes
that their ability to sit an assessment will be seriously affected by extenuating
circumstances then they should refrain from sitting the assessment and submit extenuating
circumstances in accordance with the School Policy.
11.2
Students who sit an assessment are declaring themselves fit and well enough to do so.
Students who sit assessments cannot later submit extenuating circumstances and claim
that their performance was affected. The only exception would be where a student had
been taken ill during the assessment.
11.3
To make a claim for EC’s a student must submit an Extenuating Circumstances Form
(ECF) supported by original independent documentary evidence as outlined in the School’s
Extenuating Circumstances Policy. EC’s must be submitted by the published deadline and
prior to the meeting of the Board of Examiners.
11.4
An Extenuating Circumstances Panel will meet prior to the Board of Examiners to consider
the claim and the documentary evidence and will decide whether to accept or reject the
claim based on the criteria outlined in the School’s Extenuating Circumstances Policy.
11.5
The Board of Examiners will receive the outcomes of the Extenuating Circumstances Panel
but will not have access to the details of individual cases in order to protect confidentiality.
11.9
If work is submitted late without an agreed extension the mark awarded will be penalised in
line with the UCL Policy as outlined in the UCL Academic Regulations for Undergraduate
Students, Section 3, point 3.1.7.
11.12 Once the Board of Examiners has made a decision in relation to extenuating
circumstances, no further concessions shall be made at a later date in relation to those
circumstances. Students have the right of appeal via the Schools Appeal Procedure.
8
12.
SPECIAL EXAMINATION ARRANGEMENTS
12.1
Students who have a disability and/or learning difficulty and require special examination
arrangements must submit their request in accordance with the UCL procedure.
12.2
Informing UCL of a medical condition/learning difficulty at the start of the degree
programme does not automatically lead to special examination arrangements being made.
Students are required to request special examination arrangements in accordance with this
procedure.
13.
ACADEMIC MISCONDUCT AND PLAGIARISM
13.1
Students must abide by UCL’s policy on academic misconduct and plagiarism. Failure to
do so may result in a student being required to attend a disciplinary hearing and/or Fitness
to Practise panel.
13.2
Students should ensure they have read and understood the plagiarism guidance available
on the web and in the Student Handbook. Students must also be familiar with what
constitutes an Exam Irregularity.
13.3
By sitting an examination or submitting work either in hard copy or electronically, a student
is confirming that the work submitted is exclusively their own, except where referenced, and
that work has not been submitted previously for assessment at UCL.
14.
HONOURS CLASSIFICATION
14.1
Honours classification is based on the student’s final average mark as calculated under the
appropriate scheme of award.
14.2
The classification boundaries are as follows:
Final Average mark
70% or more
at least 60% and less than 70%
at least 50% and less than 60%
at least 40% and less than 50%
less than 40%
Classification
Class 1
Class 2 - upper division
Class 2 - lower division
Class 3
Fail
15.
EXIT QUALIFICATION
15.1
An Exit Award is made where a student is unable to complete the programme for which
they were enrolled, but have completed and passed sufficient modules to be awarded a
lower level qualification. Exit Awards are not available for students who leave at the end of
the first or second years of the MPharm.
9
15.2
An Exit Award is available to students who successfully complete the first three years of the
programme (including PHAY3001 Ethics, Law and Practice 1). These students will be
eligible for the award of BSc in Pharmaceutical Studies.
The Exit Award is available to students who successfully complete the following:
Year 1 (120 credits at Level 4)
Year 2 (120 credits at Level 5)
Year 3 (60 credits at Level 6)
PHAY3001 Ethics, Law and Practice 1 (0 credit)
Year 3 and 4 (60 credits out of 180 credits at Level 7)
The degree will be weighted as follows:
Year 1
Year 2
Year 3
10% weighting of the final average mark for the year plus
30% weighting of the final average mark for the year plus
60% weighting of the final average mark for the year
15.3
The classification boundaries for the BSc Pharmaceutical Studies will be the same as for
the MPharm set out in regulations 14.2.
16.
DATE OF DEGREE AWARD
16.1
The date of the award of a degree to successful students is 1 August, but where a student
completes the degree at a time other than the Summer Exam Board, the date of award is 1
November, 31 December or 1 March, as appropriate. Please see UCL Academic
Regulations for Undergraduate Students, Section 3, point 3.1.5.
17.
PROVISION OF A DEGREE CERTIFICATE
17.1
UCL Academic Regulations for Undergraduate Students, Section 3, point 3.7.
18.
AEGROTAT DEGREES
18.1
UCL Academic Regulations for Undergraduate Students, Section 3, point 3.8.
19.
AWARD OF DEGREES, DIPLOMAS AND CERTIFICATES
19.1
UCL Academic Regulations for Undergraduate Students, Section 3, point 3.9.
20.
APPEALS
20.1
In line with the UCL Student Complaints Procedure a School level procedure provides a
framework for the informal consideration of student appeals prior to formal representation
via the UCL Student Complaints Procedure. Students cannot contest the decision of the
Board of Examiners on academic grounds. Students can only contest the results on specific
10
grounds as set out in the School Appeals Procedure.
http://www.ucl.ac.uk/pharmacy/current-students/student-information/regulations
If students are unhappy with the outcome of the appeal or believe that it has not been dealt
with appropriately then students can make a formal appeal via UCL Student Complaints
Procedure
21.
REVOCATION OF AWARDS
21.1
UCL Academic Regulations for Undergraduate Students, Section 3, point 3.11.
22.
SCHEMES OF AWARD
22.1
The annexes set out the Schemes of Award for the MPharm Degree for each year of study
based on the typical year of entry to the programme (first year and direct second year
entrants).
Annex A:
Annex B:
Annex C:
Annex D:
22.2
Students who commenced the MPharm in 2009/10
Students who commenced the MPharm in 2010/11
Students who commenced the MPharm in 2011/12
Students who commenced the MPharm in 2012/13
Students who have interrupted studies or repeated a year will usually follow the pattern of
assessment in place at the start of the relevant Part of study. Further guidance is available
from the Student and Academic Support Office (SASO).
11
Annex A - Scheme of Award (2009/10 entrants)
Annex A - YEAR 1 (2009/10)
COURSE A – THE FUNDAMENTALS OF PHARMACEUTICAL SCIENCE
4 subjects each contributing 100 marks equally weighted towards the final mark:
Subject Areas
Marks
Biochemistry*
100
Chemistry*
100
Pharmacology/Physiology*
100
Pharmacy Practice
100
Assessment Components
Coursework
Exam
Coursework
Exam
Coursework
Exam
Pharmaceutical Calculations
MCQ Exam
Pass
Weighting
marks
50%
⅓
40%
⅔
50%
⅓
40%
⅔
50%
⅓
40%
⅔
Pass/Fail
1.
1
70%
Compensation
 No compensation between Subject Areas.
 Compensation is permitted between the examination and coursework in these subject areas*
(excluding Pharmacy Practice). There must be an overall mark of at least 45% in the Subject
Area with a minimum of 35% in the exam and 35% in the CW.
COURSE B – THE SCIENTIFIC BASIS OF DISEASE
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
Progression: Students must pass Year 1 in order to progress to Year 2 of the MPharm. However,
the marks from Year 1 do not contribute to the overall degree mark.
12
Annex A - YEAR 2 (2010/11)
COURSE C - PHARMACEUTICAL AND PHARMACOLOGICAL APPROACHES TO
THERAPEUTICS
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
COURSE D – DRUG DEVELOPMENT: FROM DESIGN TO CLIENT
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
Progression: Students must pass Year 2 in order to progress to Year 3 of the MPharm. The
marks from Year 2 contribute to the overall degree mark.
13
Annex A - YEAR 3 (2011/12)
COURSE E – PHARMACY AND COMMONLY OCCURRING DISEASES
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
COURSE F – MPHARM PROJECTS
Assessment Components
Integrated Therapeutics Project
Research Project
Marks
40
160
Pass marks
50%
50%
Compensation: No compensation is permitted between the two project components.
ETHICS, LAW AND PRACTICE 1
Assessment Component
Prescription Scenarios
Marks
-
Pass marks
Pass/Fail*
* A pass is based on achieving competency in all prescription scenarios.
Progression: Students must pass Year 3 (including the Ethics, Law and Practice Course) in order
to progress to Year 4 of the MPharm. The marks from Year 3 contribute to the overall degree mark
(except for the Ethics, Law and Practice Course).
14
Annex A - YEAR 4 (2012/13)
COURSE F – OPTIONS
Assessment Components Op 1
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Assessment Components Op 2
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Compensation: A mark of 40% or higher is permitted in the examination as long as an overall
module mark of 50% is achieved. Where an option comprises two modules, compensation will be
allowed across the examination paper so that each module does not have to be passed separately.
COURSE G – PREPARATION FOR PROFESSIONAL PRACTICE (PHAYM001)
Assessment Components
Essay and Presentation
OSCE
Exam Paper 1
Exam Paper 2
Marks
100
100
100
100
Pass marks
50%
50%
50%
50%
Weighting
20%
30%
25%
25%
Compensation: A mark of 40% or higher is permitted in the examinations as long as an overall
module mark of 50% is achieved.
ETHICS, LAW AND PRACTICE 2 (PHAYM002)
Assessment Component
Examination
Marks
100
Pass mark
40%
Progression: Students must pass Year 4 (including the Ethics, Law and Practice Course) in order
to be awarded the MPharm. The marks from Year 4 contribute to the overall degree mark (except
for the Ethics, Law and Practice Course).
Final Degree Mark
Course C
Course D
Course E
Course F Projects
Option 1
Option 2
Course G (PHAYM001)
total mark out of 300 ÷ 3 x 0.125
total mark out of 300 ÷ 3 x 0.125
total mark out of 300 ÷ 3 x 0.15
total mark out of 200 ÷ 2 x 0.20
total mark out of 100 x 0.10
total mark out of 100 x 0.10
total mark out of 100 x 0.20
15
plus
plus
plus
plus
plus
plus
= final average mark
Annex B - Scheme of Award (2010/11 entrants)
Annex B - YEAR 1 (2010/11)
COURSE A – THE FUNDAMENTALS OF PHARMACEUTICAL SCIENCE
4 subjects each contributing 100 marks equally weighted towards the final mark:
Subject Areas
Marks
Biochemistry*
100
Chemistry*
100
Pharmacology/Physiology*
100
Pharmacy Practice
100
Assessment Components
Coursework
Exam
Coursework
Exam
Coursework
Exam
Pharmaceutical Calculations
MCQ Exam
Pass
Weighting
marks
50%
⅓
40%
⅔
50%
⅓
40%
⅔
50%
⅓
40%
⅔
Pass/Fail
2.
1
70%
Compensation
 No compensation between Subject Areas.
 Compensation is permitted between the examination and coursework in these subject areas*
(excluding Pharmacy Practice). There must be an overall mark of at least 45% in the Subject
Area with a minimum of 35% in the exam and 35% in the CW.
COURSE B – THE SCIENTIFIC BASIS OF DISEASE
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
Progression: Students must pass Year 1 in order to progress to Year 2 of the MPharm. However,
the marks from Year 1 do not contribute to the overall degree mark.
16
Annex B – YEAR 2 (2011/12)
COURSE C - PHARMACEUTICAL AND PHARMACOLOGICAL APPROACHES TO
THERAPEUTICS
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
COURSE D – DRUG DEVELOPMENT: FROM DESIGN TO CLIENT
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
Progression: Students must pass Year 2 in order to progress to Year 3 of the MPharm. The
marks from Year 2 contribute to the overall degree mark.
17
Annex B - YEAR 3 (2012/13)
PHAY3000
PHARMACY AND COMMONLY OCCURRING DISEASES
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
34%
33%
33%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
PHAYMX99
MPHARM PROJECTS
Assessment Components
Integrated Therapeutics Project
Research Project
Marks
100
100
Pass Marks
50%
50%
Weighting
20%
80%
Compensation: No compensation is permitted between the two project components.
PHAYM3001 ETHICS, LAW AND PRACTICE 1
Assessment Component
Prescription Scenarios
Marks
-
Pass marks
Pass/Fail*
Weighting
-
* A pass is based on achieving competency in all prescription scenarios.
Progression: Students must pass Year 3 (including the Ethics, Law and Practice Course) in order
to progress to Year 4 of the MPharm. The marks from Year 3 contribute to the overall degree mark
(except for the Ethics, Law and Practice Course).
18
Annex B - YEAR 4 (2013/14)
OPTIONS
Assessment Components Op 1
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Assessment Components Op 2
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Compensation: A mark of 40% or higher is permitted in the examination as long as an overall
Option mark of 50% is achieved. Where an option comprises two modules, compensation will be
allowed across the examination paper so that each module does not have to be passed separately.
PHAYM001
PREPARATION FOR PROFESSIONAL PRACTICE
Assessment Components
Essay and Presentation
OSCE
Exam Paper 1
Exam Paper 2
Marks
100
100
100
100
Pass marks
50%
50%
50%
50%
Weighting
20%
30%
25%
25%
Compensation: A mark of 40% or higher is permitted in the examinations as long as an overall
module mark of 50% is achieved.
PHAYM002
ETHICS, LAW AND PRACTICE 2
Assessment Component
Examination
Marks
100
Pass mark
50%
Progression: Students must pass Year 4 (including the Ethics, Law and Practice Course) in order
to be awarded the MPharm. The marks from Year 4 contribute to the overall degree mark (except
for the Ethics, Law and Practice Course).
Final Degree Mark
Course C
Course D
PHAY3000 (Course E)
PHAYMX99 Projects
Option 1
Option 2
PHAYM001 (Course G)
total mark out of 300 ÷ 3 x 0.125
total mark out of 300 ÷ 3 x 0.125
total mark out of 100 x 0.15
total mark out of 100 x 0.20
total mark out of 100 x 0.10
total mark out of 100 x 0.10
total mark out of 100 x 0.20
19
plus
plus
plus
plus
plus
plus
= final average mark
Annex C - Scheme of Award (2011/12 entrants)
Annex C - YEAR 1 (2011/12)
PHAY1000
THE FUNDAMENTALS OF PHARMACEUTICAL SCIENCE
Coursework
Term 1 Paper 1 Sections A and B
Term 2 Paper 1 Sections A and B
Practicals
Marks
100
100
100
Pass marks
50%
50%
50%
Weighting
40%
40%
20%
Assessment Components
Coursework
Exam Paper 2
Exam Paper 3
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
⅓
⅓
⅓
Compensation: No compensation is permitted in Year 1 of the MPharm.
Progression: Students must pass Year 1 in order to progress to Year 2. However, the marks from
Year 1 do not contribute to the overall degree mark.
Annex C - YEAR 2 (2012/13)
PHAY2000
THE TRANSLATION OF MEDICINES FROM LABORATORY TO PATIENT
Coursework
Calculations
Coursework (Feb)
Coursework (Jun)
Practicals
Total
Marks
100
100
100
100
100
Pass marks
50% overall
Weighting
10%
30%
30%
30%
100%
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
30%
35%
35%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
Progression: Students must pass Year 2 in order to progress to Year 3 of the MPharm. The
marks from Year 2 contribute to the overall degree mark.
20
Annex C - YEAR 3 (2013/14)
PHAY3000
PHARMACY AND COMMONLY OCCURRING DISEASES
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
34%
33%
33%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
PHAYMX99
MPHARM PROJECTS
Assessment Components
Integrated Therapeutics Project
Research Project
Marks
100
100
Pass Marks
50%
50%
Weighting
20%
80%
Compensation: No compensation is permitted between the two project components.
PHAY3001
ETHICS, LAW AND PRACTICE 1
Assessment Component
Prescription Scenarios
Marks
-
Pass marks
Pass/Fail*
Weighting
-
* A pass is based on achieving competency in all prescription scenarios.
Progression: Students must pass Year 3 (including the Ethics, Law and Practice Course) in order
to progress to Year 4 of the MPharm. The marks from Year 3 contribute to the overall degree mark
(except for the Ethics, Law and Practice Course).
21
Annex C - YEAR 4 (2014/15)
OPTIONS
Assessment Components Op 1
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Assessment Components Op 2
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Compensation: A mark of 40% or higher is permitted in the examination as long as an overall
module mark of 50% is achieved. Where an option comprises two modules, compensation will be
allowed across the examination paper so that each module does not have to be passed separately.
PHAYM001
PREPARATION FOR PROFESSIONAL PRACTICE
Assessment Components
Essay and Presentation
OSCE
Exam Paper 1
Exam Paper 2
Marks
100
100
100
100
Pass marks
50%
50%
50%
50%
Weighting
20%
30%
25%
25%
Compensation: A mark of 40% or higher is permitted in the examinations as long as an overall
module mark of 50% is achieved.
PHAYM002
ETHICS, LAW AND PRACTICE 2
Assessment Component
Examination
Marks
100
Pass mark
50%
Progression: Students must pass Year 4 (including the Ethics, Law and Practice Course) in order
to be awarded the MPharm. The marks from Year 4 contribute to the overall degree mark (except
for the Ethics, Law and Practice Course).
Final Degree Mark
PHAY2000
PHAY3000
PHAYMX99 Projects
Option 1
Option 2
PHAYM001
total mark out of 100 x 0.25
total mark out of 100 x 0.15
total mark out of 100 x 0.20
total mark out of 100 x 0.10
total mark out of 100 x 0.10
total mark out of 100 x 0.20
22
plus
plus
plus
plus
plus
= final average mark
Annex D - Scheme of Award (2012/13 entrants)
Annex D - YEAR 1 (2012/13)
PHAY1000
THE FUNDAMENTALS OF PHARMACEUTICAL SCIENCE
Coursework
Paper 1 Calculations
Paper 2 Coursework (Feb)
Paper 3 MCQ
Paper 1 Coursework (Jun)
Practicals
Marks
100
100
Pass/Fail
100
100
Pass marks
50%
50%
50%
50%
Weighting
16%
32%
32%
20%
Assessment Components
Coursework
Exam Paper 2
Exam Paper 3
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
34%
33%
33%
Compensation: No compensation is permitted in Year 1 of the MPharm. All elements have to be
passed before students can progress to Year 2.
Annex D - YEAR 2 (2013/14)
PHAY2000
THE TRANSLATION OF MEDICINES FROM LABORATORY TO PATIENT
Assessment Elements
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
30%
35%
35%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
Progression: Students must pass Year 2 in order to progress to Year 3 of the MPharm. The
marks from Year 2 contribute to the overall degree mark.
23
Annex D - YEAR 3 (2014/15)
PHAY3000
PHARMACY AND COMMONLY OCCURRING DISEASES
Assessment Components
Coursework
Exam Paper 1
Exam Paper 2
Marks
100
100
100
Pass marks
50%
40%
40%
Weighting
34%
33%
33%
Compensation: A mark of 35 or higher in one exam is permitted if the aggregate mark across both
papers is at least 40%. No compensation is permitted between exams and coursework.
Compensation is not permitted in examinations at the resit attempt and students must obtain the
minimum pass mark of 40% to pass.
PHAYMX99
MPHARM PROJECTS
Assessment Components
Integrated Therapeutics Project
Research Project
Marks
100
100
Pass Marks
50%
50%
Weighting
20%
80%
Compensation: No compensation is permitted between the two project components.
PHAY3001
ETHICS, LAW AND PRACTICE 1
Assessment Component
Prescription Scenarios
Marks
-
Pass marks
Pass/Fail*
Weighting
-
* A pass is based on achieving competency in all prescription scenarios.
Progression: Students must pass Year 3 (including the Ethics, Law and Practice Course) in order
to progress to Year 4 of the MPharm. The marks from Year 3 contribute to the overall degree mark
(except for the Ethics, Law and Practice Course).
24
Annex D - YEAR 4 (2015/16)
OPTIONS
Assessment Components Op 1
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Assessment Components Op 2
Coursework
Exam Paper
Marks
100
100
Pass marks
50%
50%
Weighting
33%
67%
Compensation: A mark of 40% or higher is permitted in the examination as long as an overall
module mark of 50% is achieved. Where an option comprises two modules, compensation will be
allowed across the examination paper so that each module does not have to be passed separately.
PHAYM001
PREPARATION FOR PROFESSIONAL PRACTICE
Assessment Components
Essay and Presentation
OSCE
Exam Paper 1
Exam Paper 2
Marks
100
100
100
100
Pass marks
50%
50%
50%
50%
Weighting
20%
30%
25%
25%
Compensation: A mark of 40% or higher is permitted in the examinations as long as an overall
module mark of 50% is achieved.
PHAYM002
ETHICS, LAW AND PRACTICE 2
Assessment Component
Examination
Marks
100
Pass mark
50%
Progression: Students must pass Year 4 (including the Ethics, Law and Practice Course) in order
to be awarded the MPharm. The marks from Year 4 contribute to the overall degree mark (except
for the Ethics, Law and Practice Course).
Final Degree Mark
PHAY2000
PHAY3000
PHAYMX99 Projects
Option 1
Option 2
PHAYM001
total mark out of 100 x 0.25
total mark out of 100 x 0.15
total mark out of 100 x 0.20
total mark out of 100 x 0.10
total mark out of 100 x 0.10
total mark out of 100 x 0.20
25
plus
plus
plus
plus
plus
= final average mark
Document Version
Version 1.0
Version 1.1
Version 1.2
Version 1.3
Version 1.4
Version 1.5
Version 1.6
Version 1.9
Version 1.10
Version 1.11
Version 1.12
Version 1.13
Version 1.14
Approved by University of London
Amended by SoP Academic Board
Amended by SoP Academic Board
Amended by SoP Academic Board
Amended by SoP Academic Board
Amended by SoP Academic Board
John Peck, Head of Registry. Added the already approved aegrotat
and exit award regulations under section 18.
John Peck, Head of Registry. Consolidated previous versions of the
regulations into one definitive document. Updated the regulations
with approved changes.
John Peck, Head of Registry. Incorporated changes to Regulations
as a result of merger with UCL. Detailed individual Schemes of
Award have been included for each year of intake up to and
including 2012/13.
John Peck, Head of Student and Academic Support. Updated to
include reference to revised School Appeals procedure.
Elizabeth Mead, Acting Head of Student and Academic Support.
Updated to amend module codes.
Elizabeth Mead, Admissions and Student Services Manager.
Changes to weighting for PHAYM002 to correct an error. Changes
to maximum period of registration to reflect UCL regulations and
GPhC regulations
Kirsty Martin, Student and Academic Support Manager – updated
2015/16 references. Added further details to the Appeal and UCL
complaints procedure and to the Exit Award
26
26 September 1997
14 October 1998
12 May 1999
19 May 2004
11 November 2009
10 November 2010
10 February 2011
01 September 2011
01 September 2012
01 September 2013
27 May 2014
23 April 2015
12 September 2015